2018 News

Chemotherapy is modern medicine’s first line of defense against cancer: chemotherapy drugs kill dividing cells by damaging DNA, preventing tumor cells from multiplying and tumors themselves from growing. To pick which chemotherapy regimens to use, oncologists rely on broad guidelines, based on the average success rates of chemotherapies. But these guidelines don’t take into account the genetic diversity of tumors, which can make some tumors drug resistant.
Kathy Giacomini
Kathy Giacomini, PhD, has been named the 2018 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy (AACP). Giacomini was selected by her AACP peers for the award, which honors the recipient’s leading research and outstanding professional contributions. The annual award is named in honor of the late Ernest H. Volwiler, a former president of Abbott Laboratories.
For her outstanding contributions to the profession of pharmacy, to society, and to UCSF, Kathleen B. Kennedy, PharmD ’78, has been named our Distinguished Alumnus of the Year.
Yiqi Cao-Bioengineering: "Don't Go Breaking My Heart...Again." Grad Slam 2018 Winner. UC San Francisco
Ten finalists battled for the Grad Slam Championship on 3/22/18. The competition was stiff, the crowd was raucous; but in the end, two BioEs swept the awards. Yiqi Cao took both 1st Place and the People’s Choice awards for her presentation “Don’t Go Breaking My Heart… Again.” You can see her winning 3-minute presentation here (starts at 49:15).  Second Place went to Inez Raharjo.
Lei Wang and Nanxi Wang
A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”
“Whole genome sequencing of pharmacogenetic drug response in racially diverse children with asthma” has been published by the American Journal of Respiratory and Critical Care Medicine (ARJCCM). “This is a huge win for the NHLBI’s TOPMed program, UCSF, and our lab”, said senior author Esteban G. Burchard, MD, MPH.
A new PharmD curriculum; Implementing new practice opportunities for pharmacists; PharmD students shine in state and national clinical pharmacy competitions; A pioneer in pharmacogenomics; The NIH streak lives on; Improving adverse event reporting and medication therapy protocols; Big-data to cut drug discovery time; Computational approaches target dopamine receptors; Researchers expose industry manipulation of science by sugar industry; Women in science; Bioengineering devices to treat glaucoma
The UCSF School of Pharmacy 2018 Mary Anne Koda-Kimble Seed Award for Innovation marked its fourth year of funding with the February 26 announcement by Dean B. Joseph Guglielmo, PharmD, of eight research award recipients. Awardees are from across the School and range from full faculty members to PharmD and PhD students.
Patricia C. Babbitt, PhD, has been named a Fellow of the International Society for Computational Biology (ISCB), an honor that recognizes scientists who have “distinguished themselves through outstanding contributions to the fields of computational biology and bioinformatics.”
Youmans and Burningham
Vice Dean Sharon Youmans shares her perspective on the School’s new PharmD curriculum.
A new study published in Circulation: Heart Failure shows how bioengineers are teaming up with clinicians to improve patient outcomes.